http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009345790-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025951c90a47d9f6c8f73b2d6725cfbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cf1689286be095e1df4abaabb4600df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b04134478f8d6597838d834657e3bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_122702a93fbf6887d1aec020525c8c79
publicationDate 2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2009345790-B2
titleOfInvention Topical solution formulations containing a corticosteroid and a cyclodextrin
abstract Solution formulations containing a corticosteroid, cyclodextrin, and xanthan gum are disclosed. The formulations are intended for topical application to the eye, ear, or nose.
priorityDate 2009-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020299-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413339604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448462053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452258638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865299

Total number of triples: 60.